CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to NTHI

Phase 2

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Past
days
NTHIPhase 2
Positive

NEO212 Oral Capsule Phase 2 Est. Readout

NEO212 Oral Capsule
Aug 12
CT.gov
Competitive Landscape

0 competitors in Diffuse Astrocytoma, IDH-Mutant

View Full Landscape
Drug Information

Target Indication

Diffuse Astrocytoma, IDH-Mutant

Clinical Trial

NCT06047379

Last updated: 2/13/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.